Streamlining Hematology Imaging Prior Auth for Advanced Diagnostics

For hematology practices, managing **hematology imaging prior auth** for advanced diagnostics like PET scans for lymphoma or MRIs for multiple myeloma staging presents unique administrative burdens.

The complexities of hematologic conditions often necessitate advanced imaging, yet securing timely prior authorizations can significantly delay patient care. Revenue cycle directors and prior authorization coordinators face the challenge of navigating diverse payer requirements and specialty benefit managers for critical diagnostic procedures. This often leads to increased administrative costs and potential treatment delays for patients with serious blood disorders.

The Intersection of Hematology and Advanced Imaging Prior Auth

Hematology encompasses a wide range of conditions, from benign blood disorders to aggressive hematologic malignancies like lymphomas and multiple myeloma. The diagnostic and staging pathways for these conditions frequently rely on advanced imaging modalities such as PET, CT, and MRI. Each of these procedures typically requires prior authorization, often managed through a complex web of payer-specific rules and third-party radiology benefit managers.

Key Prior Authorization Triggers for Imaging in Hematology

Staging and restaging of hematologic malignancies (e.g., PET-CT for lymphomas, leukemias).
Workup and monitoring of Multiple Myeloma and MGUS (e.g., MRI spine/whole body, PET-CT).
Assessment of VTE (venous thromboembolism) complications (e.g., CT venography).
Evaluation of bone marrow involvement or extramedullary disease.
Pre-transplant imaging for autologous and allogeneic stem cell transplants.

Navigating the Manual Imaging PA Landscape for Hematology

Manual processes for hematology imaging prior auth are prone to errors and delays. Staff must identify whether a specific advanced imaging order for a hematology patient requires PA, then determine if it routes through the payer directly or a specialty benefit manager like eviCore, NIA Magellan, or Carelon Medical Benefits Management (formerly AIM Specialty Health). Submissions require meticulous documentation of clinical questions, ICD-10 diagnoses, and prior treatment history, often against stringent medical necessity criteria such as ACR Appropriateness Criteria.

Klivira's Automated Approach to Hematology Imaging Prior Auth

Klivira automates the entire imaging prior authorization workflow, specifically tailored for the demands of hematology practices. By integrating with your EMR via CDS Hooks at the point of order entry, Klivira proactively identifies PA requirements for advanced imaging. Our platform automatically routes submissions to the correct payer or specialty benefit manager, including eviCore, NIA Magellan, and Carelon, ensuring all necessary clinical documentation, aligned with ASH and NCCN guidelines where applicable, is included.

Enhancing Efficiency and Patient Care in Hematology

Klivira significantly reduces the administrative burden and delays associated with hematology imaging prior auth. Our system performs pre-submission checks against ACR Appropriateness Criteria, offering alternative imaging recommendations to clinicians before a denial. This proactive approach minimizes peer-to-peer volume, accelerates approval times, and ensures hematology patients receive critical diagnostic imaging without unnecessary delays, improving throughput and patient satisfaction.

Frequently asked questions

How does Klivira handle different RBMs for hematology imaging?

Klivira's platform automatically identifies the correct radiology benefit manager (e.g., eviCore, NIA Magellan, Carelon Medical Benefits Management) based on the patient's payer and plan. It then routes the imaging prior authorization request directly to the appropriate vendor portal or Da Vinci PAS endpoint, ensuring accurate and timely submission.

Can Klivira help with imaging for conditions like multiple myeloma or lymphoma?

Yes, Klivira is designed to automate prior authorizations for advanced imaging used in hematologic oncology, such as PET-CT for lymphoma staging or MRI for multiple myeloma workup. Our system ensures that submissions include relevant clinical documentation, often guided by NCCN guidelines, to meet medical necessity criteria.

What clinical guidelines does Klivira use for imaging PA in hematology?

Klivira incorporates logic aligned with recognized clinical guidelines. For imaging prior authorizations, this primarily includes the ACR Appropriateness Criteria for medical necessity. For hematologic conditions, the system supports documentation requirements often informed by ASH guidelines and NCCN guidelines for hematologic oncology.

Does Klivira integrate with our EMR to detect imaging orders?

Yes, Klivira integrates with your EMR using standards like CDS Hooks. This enables the platform to detect advanced imaging orders at the point of clinician order entry, proactively initiating the prior authorization process and identifying requirements before the order is signed.

What if an imaging order for a hematology patient is denied by the RBM?

If an imaging order is denied, Klivira's platform facilitates the peer-to-peer review process. It surfaces the denial reason and helps streamline the scheduling and documentation required for clinicians to engage with the payer or RBM's medical director, aiming to overturn the denial based on clinical necessity.